ullous diseases affecting the skin and mucosa can have a substantial role in patients' quality of life and mental health. The most common bullous dermatoses include bullous pemphigoid and pemphigus vulgaris, which have an incidence of 4.3 and 0.1 to 0.7 per 100 000 persons worldwide, respectively. 1,2 Bullous pemphigoid and pemphigus vulgaris are both autoimmune bullous dermatoses, with antibodies to hemidesmosomes and desmoglein, respectively. 3 Epidermolysis bullosa (EB) is an inherited disorder caused by either autosomal dominant or recessive variants in genes that code structural proteins. Overall, bullous dermatoses are associated with substantial morbidity and mortality. Specifically, bullous dermatoses are associated with an increased risk of cardiovascular disease, 4 neurologic disease, 5 other autoimmune diseases, 6 and a negative outcome on quality of life. 7 Approximately 1 in 3 patients with skin disease experience depression,anddepressionhasbeenassociatedwithlowermedicationadherence and worsening disease severity among dermatology patients. 8,9 Patients with bullous skin diseases may be especially susceptible to developingmentalhealthcomorbiditiesowingtothechronicphysicaland emotional outcomes of these diseases. However, there is a critical lack of evidence synthesis on the prevalence of depression among patients with bullous skin diseases. This systematic review aims to synthesize andinterpretthecurrentevidenceondepressionanddepressivesymptoms among patients diagnosed with bullous dermatoses.
Methods
Search Strategy and Study SelectionIn conducting this review, we followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. 10 We conducted searches of the PubMed, Embase, Cochrane, and PsycInfo databases in February 2021. This systematic review was prospectively registered with PROSPERO (CRD42021230750). Database searches included articles published between 1945 and February 2021 using MeSH search terms ("Skin Diseases, Vesiculobullous" [MeSH] AND "Depression" [MeSH]), as appropriate. The initial database searches yielded a total of 271 results (Figure).Two team members, S.P.P. and Y.G., reviewed the titles and abstracts of the articles and applied inclusion and exclusion criteria to determine eligibility for this review. We also reviewed reference lists of relevant articles. For this review, inclusion criteria included patients of all ages diagnosed with bullous skin disease who were screened for depression or diagnosed with depression. Articles without primary data, case reports, and those not limited to human study were excluded. All discrepancies were mediated by A.W.A. After reviewing article titles and abstracts, S.P.P. and Y.G. determined that 36 were eligible for full-text review. IMPORTANCE There is a lack of evidence synthesis on the association between bullous skin disease and depression.OBJECTIVE To synthesize and interpret the current evidence on the association between bullous skin disease and depression.EVIDENCE REVIEW This review was co...